<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE GlossaryTerm >
<GlossaryTerm id="CDR0000579873"><TermName>Fragmin</TermName><TermPronunciation>(FRAG-min)</TermPronunciation><TermDefinition><DefinitionText>A drug used to prevent blood clots from forming or to treat blood clots that have formed in patients with cancer or other conditions. Fragmin is a type of anticoagulant. Also called dalteparin and dalteparin sodium.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></TermDefinition><MediaLink ref="CDR0000720550" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;Fragmin&quot;" language="en" id="_3"/><MediaLink ref="CDR0000720549" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;Fragmin&quot;" language="es" id="_4"/><SpanishTermName>Fragmin</SpanishTermName><SpanishTermDefinition><DefinitionText>Medicamento que se usa para prevenir la formación de coágulos de sangre o tratar los coágulos de sangre que se forman en algunos pacientes de cáncer u otras afecciones. Fragmin es un tipo de anticoagulante. También se llama dalteparina y dalteparina sódica.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></SpanishTermDefinition><DateFirstPublished>2007-12-13</DateFirstPublished><DateLastModified>2008-01-09</DateLastModified></GlossaryTerm>
